CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-15 | Reprogrammed Interchange LLC 10% owner | Sale | −400,000 | $1.64 | $656K | 33,228,487 |
| 2025-09-12 | Reprogrammed Interchange LLC 10% owner | Sale | −300,000 | $1.75 | $526K | 33,628,487 |
| 2025-09-11 | Reprogrammed Interchange LLC 10% owner | Sale | −284,805 | $1.83 | $521K | 33,928,487 |
| 2025-09-10 | Reprogrammed Interchange LLC 10% owner | Sale | −350,000 | $1.82 | $635K | 34,213,292 |
| 2025-09-09 | Reprogrammed Interchange LLC 10% owner | Sale | −449,226 | $2.00 | $899K | 34,563,292 |
| 2025-09-08 | Reprogrammed Interchange LLC 10% owner | Sale | −464,421 | $1.99 | $924K | 35,012,518 |
| 2025-09-08 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2025-09-08 | Reed Sarah Burgess Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2025-09-05 | Reprogrammed Interchange LLC 10% owner | Sale | −400,000 | $1.97 | $787K | 35,476,939 |
| 2025-09-04 | Reprogrammed Interchange LLC 10% owner | Sale | −453,016 | $1.93 | $874K | 35,876,939 |
| 2025-09-03 | Reprogrammed Interchange LLC 10% owner | Sale | −554,612 | $2.00 | $1.1M | 36,329,955 |
| 2025-08-28 | Reprogrammed Interchange LLC 10% owner | Sale | −806,351 | $2.01 | $1.6M | 36,884,567 |
| 2025-08-27 | Reprogrammed Interchange LLC 10% owner | Sale | −611,647 | $2.01 | $1.2M | 37,690,918 |
| 2025-08-26 | Reprogrammed Interchange LLC 10% owner | Sale | −284,190 | $2.08 | $591K | 38,302,565 |
| 2025-08-25 | Reprogrammed Interchange LLC 10% owner | Sale | −387,346 | $2.12 | $820K | 38,586,755 |
| 2025-07-17 | Zuraw Qing Che Chief Development Officer | Grant or award | +937,080 | 937,080 | ||
| 2025-07-17 | Zuraw Qing Che Chief Development Officer | Grant or award · Employee Stock Option (right to buy) | +4,373,040 | 4,373,040 | ||
| 2025-07-16 | Detheux Michel Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-07-16 | Cumbo Alexander Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2025-07-09 | Mahatme Sandesh CFO | Grant or award | +13,882,750 | 13,882,750 |
Page 6 of 18 · 344 trades